Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-30 Purchase | 2024-01-31 4:11 pm | ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner | 444,444 | $18 | $7,999,992 | 1,513,664 (Indirect) | View |
| 2024-01-25 Purchase | 2024-01-26 7:13 pm | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 3,125,000 | $2.4 | $7,500,000 | 2,930,527 (Indirect) | View |
| 2023-07-17 Purchase | 2023-07-19 4:17 pm | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 479,932 | $3.05 | $1,463,793 | 650,600 (Indirect) | View |
| 2023-06-27 Purchase | 2023-06-29 4:51 pm | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 875,000 | $2.09 | $1,828,750 | 962,339 (Indirect) | View |
| 2023-05-04 Purchase | 2023-05-08 5:11 pm | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 1,460,932 | $2.797 | $4,086,235 | 1,902,937 (Indirect) | View |
| 2023-04-28 Purchase | 2023-05-02 9:38 pm | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 1,405,168 | $2.6146 | $3,673,901 | 1,328,967 (Indirect) | View |
| 2023-02-27 Purchase | 2023-03-17 4:29 pm | BiomX Inc. | PHGE | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner | 348,000 | $0.245 | $85,260 | 4,951,448 (Indirect) | View |
| 2022-12-23 Purchase | 2022-12-28 5:46 pm | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 137,931 | $7.25 | $1,000,000 | 7,619,135 (Indirect) | View |
| 2022-11-08 Purchase | 2022-11-10 4:38 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 402,000 | $3.21 | $1,290,420 | 18,791,422 (Indirect) | View |
| 2022-11-07 Purchase | 2022-11-09 4:29 pm | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 192,000 | $5.21 | $1,000,320 | 17,233,668 (Indirect) | View |
| 2022-08-16 Purchase | 2022-08-18 4:50 pm | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 3,690,000 | $2.42 | $8,929,800 | 1,072,400 (Indirect) | View |
| 2022-05-11 Purchase | 2022-05-13 5:48 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 192,516 | $2.1841 | $420,482 | 18,389,422 (Indirect) | View |
| 2022-05-06 Purchase | 2022-05-10 6:19 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 125,359 | $1.5735 | $197,252 | 18,196,906 (Indirect) | View |
| 2022-02-11 Purchase | 2022-02-15 9:51 pm | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director | 195,700 | $10.17 | $1,989,446 | 4,043,629 (Indirect) | View |
| 2022-01-19 Purchase | 2022-01-21 7:22 pm | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 158,417 | $9.9656 | $1,578,717 | 17,041,802 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 7:27 pm | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 44,717 | $9.9012 | $442,750 | 16,883,385 (Indirect) | View |
| 2021-11-04 Purchase | 2021-11-08 9:12 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 5,357,143 | $3.5 | $18,750,001 | 3,571,428 (Indirect) | View |
| 2021-10-12 Purchase | 2021-10-14 5:00 pm | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 625,000 | $16 | $10,000,000 | 499,150 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-03 Disposition | 2024-04-05 4:39 pm | N/A 2030-12-02 | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 8,095,480 | $0 | 0 (Direct) | View |
| 2024-02-14 Disposition | 2024-02-14 4:01 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 3,250 | $0 | 0 (Direct) | View |
| 2024-02-14 Equity Swap | 2024-02-14 4:01 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 17,713,600 | $0 | 0 (Indirect) | View |
| 2024-02-09 Option Award | 2024-02-14 12:02 pm | N/A 2034-02-08 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-01-30 Conversion | 2024-01-31 4:11 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner | 2,582,884 | $0 | 1,513,664 (Indirect) | View |
Ownership | 2024-01-25 8:36 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner | 0 | $0 | 2,582,884 (Indirect) | View |
| 2023-08-14 Disposition | 2023-08-16 6:08 pm | N/A 2030-09-16 | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 93,400 | $0 | 93,400 (Direct) | View |
| 2023-08-14 Option Award | 2023-08-16 6:08 pm | N/A 2030-09-16 | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 93,400 | $0 | 93,400 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:01 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 6:29 pm | N/A 2033-06-12 | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 5:29 pm | N/A 2033-06-12 | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 22,750 | $0 | 22,750 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:48 pm | N/A 2033-06-05 | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 5:47 pm | N/A 2033-05-31 | Adicet Bio Inc. | ACET | GORDON CARL L Director | 32,300 | $0 | 32,300 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 4:30 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 550,000 | $0 | 4,593,629 (Indirect) | View |
| 2023-02-08 Option Award | 2023-02-09 4:28 pm | N/A 2033-02-07 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:00 pm | N/A 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 5:00 pm | N/A 2032-06-13 | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director | 20,250 | $0 | 20,250 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 8:10 pm | N/A 2032-06-09 | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:42 pm | N/A 2032-06-01 | Adicet Bio Inc. | ACET | GORDON CARL L Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:25 pm | N/A 2032-05-31 | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 8,293 | $0 | 8,293 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-23 5:45 pm | N/A 2032-02-17 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-12-10 Option Award | 2021-12-14 7:06 pm | N/A N/A | Adicet Bio Inc. | ACET | GORDON CARL L Director 10% Owner | 214,285 | $14 | 7,475,141 (Indirect) | View |
| 2021-10-12 Conversion | 2021-10-14 5:00 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 31,990,686 | $0 | 499,150 (Indirect) | View |
| 2021-10-06 Option Award | 2021-10-08 7:00 pm | N/A 2031-10-05 | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 22,678 | $0 | 22,678 (Direct) | View |
Ownership | 2021-10-06 7:00 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 0 | $0 | 16,213,668 (Indirect) | View |